The global autoimmune
treatment market is
growing significantly due to increasing incidences of autoimmune diseases, up
surging healthcare expenditure, and advancements in the technologies for the
development of autoimmune diseases therapeutics. Autoimmune diseases are
chronic in nature and do not have permanent treatment. This creates ample
growth opportunity for the autoimmune treatment market, to grow at a considerable
rate in the coming years. The advanced research and development facilities, and
new product developments by the companies are propelling the demand for cost
effective treatment of autoimmune diseases.
The abnormal response of immune system
leads to autoimmune disorders. Normally, the body’s immune system provides
protection against foreign bodies or harmful substances. However, in the
autoimmune disorders, the immune system fails to differentiate between a
healthy tissue or cell and a harmful substance (antigen), and destroys the
normal tissues. Autoimmune diseases have high prevalence among female children
and women. There are more than 80 prevailing autoimmune diseases. Some of the
most common autoimmune disorders include psoriasis, multiple sclerosis,
rheumatoid arthritis, type 1 diabetes, systemic lupus erythematosus,
inflammatory bowel disease, and Addison’s disease.
Request to
Get the Report Sample Pages at:
Make
Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=autoimmune-treatment-market
Geographically, North America leads the
global autoimmune treatment market, due to aging population, high incidences of
autoimmune diseases, increased healthcare expenditure, and excessive R&D
investment for the development of drugs for autoimmune diseases. Asia-Pacific
is the fastest growing region in the global autoimmune treatment market. The
major reasons for the fastest growth in the region are increasing healthcare
expenditure and improving healthcare infrastructure. Moreover, the autoimmune
treatment market is growing, due to increasing disposable income and large
population suffering from autoimmune diseases in the emerging countries, such
as India and China.
Some of the major players operating in
the global autoimmune treatment market are Abott, Bristol-Myers Squibb Company,
Amgen Inc., Pfizer Inc., Bayer AG, F. Hoffmann-La Roche AG, Eli Lilly and
Company, Novartis AG, Johnson & Johnson Services Inc., Merck & Co.
Inc., Sanofi, GlaxoSmithKline PLC, Biogen, Boehringer Ingelheim GmbH,
AstraZeneca PLC, and Astellas Pharma Inc.
About P&S Intelligence
P&S Intelligence, a brand of P&S
Market Research, is a provider of market research and consulting services
catering to the market information needs of burgeoning industries across the
world. Providing the plinth of market intelligence, P&S as an enterprising
research and consulting company, believes in providing thorough landscape
analyses on the ever-changing market scenario, to empower companies to make informed
decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886
(USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
No comments:
Post a Comment